Vincent Serra
Geschäftsführer bei NEOVACS
Aktive Positionen von Vincent Serra
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEOVACS | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Geschäftsführer | - | - | |
| Vorstandsvorsitzender | - | - | |
| BioSupport AG | Corporate Officer/Principal | - | - |
Karriereverlauf von Vincent Serra
Ehemalige bekannte Positionen von Vincent Serra
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Vorstandsvorsitzender | 01.08.2005 | 01.02.2014 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.08.2005 | 01.02.2014 | |
| Gründer | 22.12.2009 | 01.02.2014 | |
Anosys, Inc.
 Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Corporate Officer/Principal | 03.01.1999 | 01.02.2005 |
| ABIVAX | Corporate Officer/Principal | - | - |
Ausbildung von Vincent Serra
| University of Grenoble | Doctorate Degree |
Statistik
International
| Frankreich | 4 |
| 2 | |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABIVAX | Health Technology |
| NEOVACS | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Health Technology |
| BioSupport AG |
- Börse
- Insiders
- Vincent Serra
- Erfahrung
